Abeona Therapeutics
NasdaqCM:ABEO
$ 4,91
$-0,21 (-4,10%)
4,91 $
$-0,21 (-4,10%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,60
Earnings Per Share
-
Revenue Per Share
41,15%
Gross Margin %
$0,28 B
Market Cap
$0,01 B
Long-Term Debt
Earnings Per Share
$-1,60
Revenue Per Share
-
Gross Margin %
41,15%
Market Cap
$0,28 B
Long-Term Debt
$0,01 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2011 2010 2009 2008
EPS Earnings Per Share $-1,60 $-1,53 $-1,94 $-5,87 $-23,28 $-22,75 $-37,75 $-29,75 $-16,50 $-16,00 $-13,25 $-581,50 $-766,25 $-2.037,50 $-4.387,50
Earnings Earnings $-77,65M $-74,25M $-53,08M $-103,96M $-137,35M $-89,86M $-126,09M $-57,12M $-31,19M $-25,76M $-17,36M $-11,63M $-15,33M $-20,38M $-0,00M
RPS Revenue Per Share $0,00 N/A $0,00 $0,13 $0,08 $0,51 $2,53 $0,00 $1,56 $0,44 $0,55 $0,76 $92,50 $24,00 $35,00 N/A
Revenue Revenue $0,00M $5,82M $0,00M $3,50M $1,41M $3,00M $10,00M $0,00M $3,00M $0,84M $0,89M $1,00M $1,85M $0,48M $0,35M $0,29M
OCF Operating Cash Flow $0,00M $0,00M $-56,02M $0,00M $0,00M $0,00M $-35,02M $-62,82M $-39,11M $0,00M $-13,01M $-10,42M $0,00M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $-36,36M $-69,13M $-48,35M $-28,18M $-13,53M $-10,73M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% -32,01% -10,92% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 41,15% 0,00% 23,14% 0,96% -9,97% -201,39% 0,00% 0,00% 0,00% 0,00% 100,00% 91,95% 0,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share $0,00 $-1,59 $-1,42 $-1,75 $-5,55 $-17,73 $-9,81 $-34,42 $-30,83 $-14,12 $-9,90 $-9,72 $-478,45 $-549,10 $-9,52 $-55,99
LT Debt Long-Term Debt N/A $7,81M $13,04M N/A N/A N/A $1,43M N/A N/A N/A N/A N/A N/A N/A $5,50M $5,50M
Sha. Stocks 57,05M 48,53M 48,53M 27,36M 17,71M 5,9M 3,95M 3,34M 1,92M 1,89M 1,61M 1,31M 0,02M 0,02M 0,01M 0,01M
×